Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.60    0.20 (0.06%)
Bid:
343.60
Ask:
344.80
Spread: 1.20 (0.349%)
Market Cap: £2.52b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Director Declaration

16 Nov 2018 15:42

RNS Number : 6692H
TP ICAP PLC
16 November 2018
 

TP ICAP PLC

 

16 November 2018

 

TP ICAP plc confirms regulatory approval of Nicolas Breteau

 

Following the appointment of Nicolas Breteau as Chief Executive on 10 July 2018, TP ICAP plc (the "Company") is pleased to confirm that on 14 November 2018 it received regulatory approval from the Financial Conduct Authority of Mr Breteau's appointment as Executive Director (CF1) at Tullet Prebon (Securities) Limited, ICAP Securities Limited and iSwap Euro Limited.

 

There are no other details that are required to be disclosed in respect of Mr Breteau's appointment under Paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

 

ENDS

 

Media enquiries:

 

Jamie Dunkley

Jamie.Dunkley@tpicap.com

+44 (0) 20 7200 7524

 

About TPICAP

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

 

About Nicolas Breteau

Nicolas Breteau has extensive experience across the global broking industry. He joined Tullett Prebon as Chief Commercial Officer in 2016, and then moved to run TP ICAP's largest business, Global Broking.

Nicolas started his career in 1993 on the Listed Derivatives Exchange MATIF (later part of Euronext). From 1993 to 1998, he held several senior positions at the derivatives broker FIMAT, including Deputy CEO of the

Paris Office. He then moved to London as Head of Risk for EMEA, and subsequently became Deputy CEO then CEO of the FIMAT London Branch.

In 2005, Nicolas was promoted to CEO of EMEA, a position he consolidated after Newedge was formed through the merger of FIMAT with Calyon Financial in 2008. He was appointed Global Head of Sales and Front-Office in 2009 and became Chief Executive of Newedge Group in 2010. He moved from Newedge in 2014 following the sale of the company to Société Générale, and became Senior Managing Partner of a consulting firm, 99 Advisory.

Nicolas graduated from Ecole Superieure de Commerce de Bordeaux. He has been a director of several Boards including the Futures and Options Association (UK), Futures Industry Association (USA), Altura (Spain), Citic/Newedge (China) and has been the chairman of i-swap since February 2018.

He is a trustee at PSE For a Child's Smile UK, which helps deprived children in Cambodia.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNUNSVRWRAAAAA
Date   Source Headline
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20254:45 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20254:30 pmRNSHolding(s) in Company
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:05 amRNSLaunch of fourth share buyback programme of £30m
11th Mar 20257:00 amRNSFinal Results
6th Mar 20254:35 pmRNSHolding(s) in Company
13th Feb 20258:00 amRNSHolding(s) in Company
10th Feb 20254:30 pmRNSHolding(s) in Company
23rd Jan 20255:30 pmRNSDirectorate Change
17th Jan 20252:45 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 202410:21 amRNSHolding(s) in Company
20th Dec 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20244:15 pmRNSHolding(s) in Company
13th Nov 20243:00 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:05 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTrading Statement
4th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.